Back to Agenda
ICH 30th Anniversary: Achievements and Future Prospects
Session Chair(s)
Amanda Marie Roache, MS
Senior Director, Science and Regulatory Advocacy
Pharmaceutical Research and Manufacturers of America (PhRMA), United States
This session will celebrate the key successes of the ICH Association in recognition of its 30th anniversary highlighting how the Association has evolved to respond to the increasingly global market and new advances in pharmaceutical development.
Learning Objective : Identify key accomplishments of the ICH Association since it was founded in 1990; Discuss how ICH guidelines have contributed to more efficient drug development and increased patient access to pharmaceuticals worldwide; Explain how the reforms completed in 2015 have expanded the global reach of ICH and increased participation from regulators and industry around the world.
Speaker(s)
MHLW/PMDA Perspective
Nobumasa Nakashima
Cabinet Office, Japan
Health Policy Director, National Healthcare Policy Secretariat
European Commission Perspective
Lenita Lindström, LLM
European Commission, Belgium
ICH Assembly Chair and Senior Expert, European Commission
FDA Perspective
Theresa Mullin, PhD
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
IGBA Perspective
Nicholas Cappuccino, PhD
Dr. Reddy's Laboratories, United States
Chair, IGBA Science Committee; Consultant, Compliance, Quality & Sci Affairs
Panelist
Peter Honig, MD, MPH, FACP
Advisor and Board Member, United States
Panelist
Celia Lourenco, PhD
Health Canada, Canada
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB
Have an account?